IASR Vol.42, No.8(No.498) August 2021 Vancomycin-resistant enterococcus (VRE) infection in Japan
Published: 26 December 2024
PDFdownload(PDF:449.56KB)
Vancomycin-resistant enterococcus (VRE) infection in Japan
- Drug resistance mechanisms of vancomycin-resistant enterococci (VRE)
- Overview of vancomycin-resistant enterococci (VRE) testing at the Osaka Institute of Public Health
- Screening methods employed for vancomycin-resistant enterococci (VRE) during an outbreak
- Vancomycin-resistant enterococci (VRE) outbreak in a cancer hospital in 2021
- Clinical manifestations and treatment of vancomycin-resistant enterococci (VRE)
- Detection and emergence of new epidemic strains of vancomycin-resistant enterococci (VRE) overseas
- Increase in vancomycin-resistant enterococci (VRE) among livestock and possible transmission to humans via imported meat
- Active epidemiological investigation of COVID-19 cases diagnosed after COVID-19 vaccination (first report), April- June 2021
- Food poisoning outbreak due to norovirus G2.17 [P17] at multiple restaurants that employed the same food handler, Tokyo, February 2021
- Epidemiological analysis of COVID-19 symptoms, Kanagawa Prefecture, April-May 2020
- Analysis of replacement of SARS-CoV-2 strains with a variant carrying the N501Y mutation in Japan